Generate a tailored SOP for Dr. Lori Lewis. Improve your application with a focused, well-structured draft.
Lori joined the Australian Lymphoedema Education, Research, and Treatment (ALERT) Centre in 2017 as a Senior Research Officer. She is involved in the PREVENT Study, which is an international project focused on prospective surveillance and early intervention for women at risk of lymphoedema due to breast cancer treatment. Lori contributes to various studies within the ALERT research team. Her academic qualifications include a Bachelor of Science in Physiotherapy from Curtin University, completed in 1991, and she is currently undertaking a Master of Research, with a thesis exploring body composition and chemotherapy toxicities in women undergoing breast cancer treatment. This thesis is expected to be completed by April 2024. Lori also completed the ALERT Level 1 Lymphoedema Accreditation Training Program in 2020. In her current role, she is responsible for writing study protocols, submitting ethics applications, and coordinating clinical trials, while working closely with the ALERT team on research initiatives. Additionally, she collaborates with a multidisciplinary team at MQ Health Lymphoedema Clinic, where she plays an active role in diagnostic, surgical, and lipoedema clinics.
ALERT • Sydney, Australia
Involved in the PREVENT Study, focusing on lymphoedema risk due to breast cancer treatment.
Applied to Department of Business (MBA Program).